# Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye

> **NCT02951975** · — · TERMINATED · sponsor: **Allergan** · enrollment: 246 (actual)

## Conditions studied

- Non-infectious Uveitis

## Interventions

- **DRUG:** dexamethasone intravitreal implant

## Key facts

- **NCT ID:** NCT02951975
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-25
- **Primary completion:** 2018-11-28
- **Final completion:** 2018-12-19
- **Target enrollment:** 246 (ACTUAL)
- **Why stopped:** Business decision to stop the program.
- **Last updated:** 2019-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02951975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02951975, "Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02951975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*